Centre de Recherche du CHUM

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Prostate cancer3 trials
• Cervical cancer1 trial
• Colorectal cancer1 trial
• Coronary artery disease1 trial
• Huntington's disease1 trial
• Multiple myeloma1 trial

Phase

• Phase 35 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Recruiting3 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Janssen Research & Development, LLC5 trials
• Centre hospitalier de l'Université de Montréal (CHUM)1 trial
• Novartis Pharmaceuticals1 trial
• Teva Branded Pharmaceutical Products R&D LLC1 trial

Running trials

• Recruiting

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Martine Comeau

• Recruiting

  A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT07225946· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  NCT06662786· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

  NCT03748641· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

  NCT03431350· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers

  NCT01051895· Centre hospitalier de l'Université de Montréal (CHUM)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Huntington's disease1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Terminated

  A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT03215030· Phase 1/2· Teva Branded Pharmaceutical Products R&D LLC· Source